“The question becomes, ‘Okay, well, how long exactly is it persisting? Is it ever being degraded? Is the fact that it is persisting a lot longer increasing the potential for it to be transported into the nucleus and integrated into the genome?’” inquired former Merck and biotech research scientist Mike Donio.

Mike Donio shares his insights on modified mRNA technology and DNA contamination by harkening back to his extensive experience in drug discovery and clinical trials with Brian Hooker on #CHDTV.